182 related articles for article (PubMed ID: 25287914)
41. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
Mandai K; Uno K; Yasuda K
Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
[TBL] [Abstract][Full Text] [Related]
42. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis.
Zhao W; Liu S; Cong L; Zhao Y
Ann Surg Oncol; 2022 Feb; 29(2):1297-1312. PubMed ID: 34554343
[TBL] [Abstract][Full Text] [Related]
43. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
44. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.
Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ
Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913
[TBL] [Abstract][Full Text] [Related]
45. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
46. Should we regard all main duct type intraductal papillary mucinous neoplasms of the pancreas (MD-IPMN) as an indication of surgery? -A retrospective study in 29 patients with MD-IPMN showing mural nodules.
Masaki Y; Koshita S; Noda Y; Kanno Y; Ogawa T; Masu K; Sawai T; Ito K
Pancreatology; 2019 Mar; 19(2):352-359. PubMed ID: 30679137
[TBL] [Abstract][Full Text] [Related]
47. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC).
Duconseil P; Adham M; Sauvanet A; Autret A; Périnel J; Chiche L; Mabrut JY; Tuech JJ; Mariette C; Turrini O
Ann Surg Oncol; 2018 Apr; 25(4):1017-1025. PubMed ID: 29392508
[TBL] [Abstract][Full Text] [Related]
48. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
49. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
[TBL] [Abstract][Full Text] [Related]
51. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
[TBL] [Abstract][Full Text] [Related]
52. Main-duct intraductal papillary mucinous adenoma of the pancreas.
Takuma K; Kamisawa T; Tabata T; Kurata M; Honda G; Horiguchi S
World J Surg Oncol; 2011 Nov; 9():153. PubMed ID: 22112163
[TBL] [Abstract][Full Text] [Related]
53. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
54. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
[TBL] [Abstract][Full Text] [Related]
55. "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Aso T; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Osoegawa T; Takahata S; Shindo K; Ushijima Y; Aishima S; Oda Y; Ito T; Mizumoto K; Tanaka M
Pancreas; 2014 Nov; 43(8):1239-43. PubMed ID: 25036910
[TBL] [Abstract][Full Text] [Related]
56. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
57. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasms.
Yamada S; Fujii T; Murotani K; Kanda M; Sugimoto H; Nakayama G; Koike M; Fujiwara M; Nakao A; Kodera Y
Surgery; 2016 Mar; 159(3):878-84. PubMed ID: 26506564
[TBL] [Abstract][Full Text] [Related]
59. Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm.
Hackert T; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW
Ann Surg; 2015 Nov; 262(5):875-80; discussion 880-1. PubMed ID: 26583679
[TBL] [Abstract][Full Text] [Related]
60. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
